Antibody Persistence, Immune Response and Safety After Doses of Pentabio Vaccine

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

399

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

December 31, 2014

Conditions

Healthy

Interventions

BIOLOGICAL

Pentavalen

Batch 5010613

Trial Locations (6)

Jatinegara Primary Health Center, Jakarta

Mampang Prapatan Primary Health Center, Jakarta

Tebet Primary Health Center, Jakarta

Garuda Primary Health Center, Bandung

Ibrahim Adjie Primary Health Center, Bandung

Puter Primary Health Centre, Bandung